文献速递胃肠外科围术期管理与 ERAS

腹腔镜次全结肠切除联合右下腹双端回肠乙状结肠造口利于炎症性肠病二期手术

Laparoscopic subtotal colectomy with double-end ileosigmoidostomy in right iliac fossa facilitates second-stage surgery in patients with inflammatory bowel disease.
PubMed 文献 · Surg Endosc · 2019-03-14

该多中心回顾性研究纳入1999至2017年213例因炎症性肠病行腹腔镜次全结肠切除联合右下腹双端回肠乙状结肠造口的患者,评估其安全性和对二期手术的影响。结果显示术后死亡1例(0.5%),主要并发症18例(8%),94%患者完成二期手术,其中96%的IPAA可经腹腔镜完成。

要点

  • 腹腔镜次全结肠切除加右下腹双端造口安全可行,中转开腹率4%。
  • 94%患者完成二期手术,平均延迟4.7个月。
  • IPAA二期手术96%可经腹腔镜完成,回肠直肠吻合100%可经择期切口或腹腔镜完成。

核心结论

  • 腹腔镜次全结肠切除联合右下腹双端回肠乙状结肠造口安全可行,并便于二期手术恢复肠道连续性。

研究设计与样本

  • 回顾性多中心研究,纳入2个欧洲专家中心1999至2017年因炎症性肠病行腹腔镜次全结肠切除联合右下腹双端回肠乙状结肠造口的213例连续患者。

主要发现

  • 急诊手术74例(35%),中转开腹9例(4%),术后死亡1例(0.5%)。
  • 次全结肠切除术后并发症53例(25%),其中主要并发症18例(8%)。
  • 二期手术199例(94%),平均延迟4.7±6个月(范围1.4-77)。
  • 二期手术中回肠直肠吻合50/199例(25%),68%经右下腹择期切口完成;IPAA 139例(70%),96%经腹腔镜完成;腹会阴切除加末端回肠造口10例(5%),8例经腹腔镜完成。
  • 二期术后并发症53例(27%),主要并发症15例(8%);平均随访3.7±3年(范围0.1-15),造口率17%,小肠梗阻10例(5%),切口疝25例(12%)。

临床怎么用

  • 对于炎症性肠病需行次全结肠切除者,可考虑腹腔镜联合右下腹双端回肠乙状结肠造口,以便二期手术经切口或腹腔镜完成。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: There is no consensus about the most appropriate management of rectal stump in laparoscopic subtotal colectomy (STC) performed for inflammatory bowel disease (IBD). The objective is to report our experience of laparoscopic STC with double-end ileosigmoidostomy in the right iliac fossa for IBD. METHODS: All patients undergoing laparoscopic STC and double-end ileosigmoidostomy in the right iliac fossa for IBD in 2 European expert centres were included. RESULTS: From 1999 to 2017, laparoscopic STC and double-end ileosigmoidostomy in right iliac fossa was performed in 213 consecutive patients, including 74 patients in an emergency setting (35%). Conversion to laparotomy was necessary in 9 patients (4%). One patient died postoperatively (0.5%). Postoperative morbidity occurred in 53 patients (25%) after STC, and was major in 18 patients (8%). A second stage was performed in 199 patients (94%), with a mean delay of 4.7 ± 6 months (range 1.4-77). The second stage was an ileorectal anastomosis (n = 50/199; 25%), performed by an elective open incision in the right iliac fossa in 68% of cases; an ileal pouch-anal anastomosis (IPAA) (n = 139; 70%) successfully performed by laparoscopy in 96% of cases; or an abdominoperineal excision with end ileostomy (n = 10; 5%) successfully performed by laparoscopy in 8 cases. After this second stage, postoperative morbidity occurred in 53 patients (27%), and was major in 15 patients (8%). After a mean follow-up of 3.7 ± 3 years (range 0.1-15), stoma rate (end ileostomy and diverting stoma not closed) was 17%, and small bowel obstruction and incisional hernia occurred in 10 (5%) and 25 (12%) patients, respectively. CONCLUSIONS: Laparoscopic STC and double-end ileosigmoidostomy in right iliac fossa is safe, feasible, and facilitates the second stage for intestinal continuity by either elective incision or laparoscopy in 100% of ileorectal anastomoses and by laparoscopy in 96% of IPAA.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Mege D, Frontali A, Pellino G, et al. Laparoscopic subtotal colectomy with double-end ileosigmoidostomy in right iliac fossa facilitates second-stage surgery in patients with inflammatory bowel disease. Surg Endosc. 2019. PMID: 30877564. doi:10.1007/s00464-019-06749-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。